Effects of Indralin on Immunohematological Parameters and DNA Damage in Irradiated ICR (CD-1) Outbred Mice


Дәйексөз келтіру

Толық мәтін

Ашық рұқсат Ашық рұқсат
Рұқсат жабық Рұқсат берілді
Рұқсат жабық Тек жазылушылар үшін

Аннотация

Abstract—Intragastric administration of radioprotector indralin (B-190 drug) to outbred SPF ICR (CD-1) mice 15 minutes before X-ray irradiation at doses of 6 Gy (LD-10/30), 6.5 Gy, and 7 Gy (LD-100/30) increases the 30-day survival of the animals and positively affects the state of the central organs of immunity and hematopoiesis, as well as the number of peripheral blood leukocytes. In addition, a positive effect on the behavioral reactions of the irradiated animals and striated muscles strength was noted. In addition to these secondary features of the indralin positive effect, a significant reduction of radiation-induced DNA damage in spleenocytes was observed using flow cytometry analysis of phosphorylated histone Н2АХ (γН2АХ) (1 h and eight days after X-ray irradiation) and DNA-comet assay (eight days after X-ray irradiation). The abovementioned methods are recommended for experiments investigating the influence of radioprotective drugs on DNA damage induction and repair in the irradiated organism, as well as for initial searching of potential radioprotectors and assessment of their effectiveness level in clinical practice and experiments.

Авторлар туралы

A. Bushmanov

State Research Center—Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency

Email: a1931192@mail.ru
Ресей, Moscow

A. Osipov

State Research Center—Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency; Semenov Institute of Chemical Physics, Russian Academy of Sciences

Email: a1931192@mail.ru
Ресей, Moscow; Moscow

M. Ignatov

State Research Center—Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency

Email: a1931192@mail.ru
Ресей, Moscow

M. Vorontsova

State Research Center—Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency

Email: a1931192@mail.ru
Ресей, Moscow

T. Karaulova

State Research Center—Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency

Email: a1931192@mail.ru
Ресей, Moscow

A. Gordeev

State Research Center—Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency

Email: a1931192@mail.ru
Ресей, Moscow

E. Yashkina

State Research Center—Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency

Email: a1931192@mail.ru
Ресей, Moscow

O. Nikitenko

State Research Center—Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency; Federal State Budgetary Institution of Science “Russian Federation State Scientific Center—Institute of Biomedical Problems,” Russian Academy of Sciences

Email: a1931192@mail.ru
Ресей, Moscow; Moscow

T. Bychkova

State Research Center—Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency; Federal State Budgetary Institution of Science “Russian Federation State Scientific Center—Institute of Biomedical Problems,” Russian Academy of Sciences

Email: a1931192@mail.ru
Ресей, Moscow; Moscow

N. Stavrakova

State Research Center—Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency

Email: a1931192@mail.ru
Ресей, Moscow

I. Andrianova

State Research Center—Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency

Email: a1931192@mail.ru
Ресей, Moscow

T. Blokhina

State Research Center—Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency; Semenov Institute of Chemical Physics, Russian Academy of Sciences

Email: a1931192@mail.ru
Ресей, Moscow; Moscow

N. Vorobyeva

State Research Center—Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency; Semenov Institute of Chemical Physics, Russian Academy of Sciences

Email: a1931192@mail.ru
Ресей, Moscow; Moscow

A. Ivanov

State Research Center—Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency; Federal State Budgetary Institution of Science “Russian Federation State Scientific Center—Institute of Biomedical Problems,” Russian Academy of Sciences; Joint Institute for Nuclear Research

Хат алмасуға жауапты Автор.
Email: a1931192@mail.ru
Ресей, Moscow; Moscow; Dubna

Қосымша файлдар

Қосымша файлдар
Әрекет
1. JATS XML

© Pleiades Publishing, Inc., 2019